Related Experiment Video
Updated: May 5, 2026

10:27
Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
Published on: December 5, 2019
10.3K
Overexpression of the Ubiquitin Ligase RNF182 Is Associated with High-Grade Gliomas
Veronica Russo1, Miriam Russo1, Maria Antonietta Oliva1
1IRCCS Neuromed, 86077 Pozzilli, Italy.
Cancers
|May 4, 2026
Summary
Researchers identified the RING ligase RNF182 as a key driver of glioblastoma (GBM) growth. Inhibiting RNF182 significantly reduced GBM cell proliferation, suggesting it is a potential therapeutic target for this aggressive brain cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Glioblastoma (GBM) is the most aggressive adult brain tumor.
- Dysregulation of the ubiquitination system contributes to GBM growth and treatment resistance.
- Specific ubiquitin-proteasome system targets in GBM remain poorly understood.
Purpose of the Study:
- To investigate the role of the ubiquitin-proteasome system in glioblastoma.
- To identify novel molecular targets for GBM treatment.
Main Methods:
- In silico analysis
- Immunohistochemistry
- Western blot
- RT-qPCR
- Gene silencing (siRNA)
- Proliferation assays
Main Results:
- Aggressive gliomas, particularly glioblastoma, exhibit elevated expression of the RING ligase RNF182 compared to low-grade gliomas.
- Higher RNF182 levels strongly correlate with increased GBM tumor growth.
- siRNA-mediated inhibition of RNF182 in U87MG glioblastoma cells significantly reduced cell proliferation.
Conclusions:
- RNF182 plays a crucial role in promoting unchecked glioblastoma cell proliferation.
- RNF182 represents a novel molecular marker associated with GBM progression.
- RNF182 is a potential therapeutic target for glioblastoma treatment.
Related Concept Videos
The Retinoblastoma Gene
3.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
The Ras Gene
5.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
5.7K
Small GTPases - Ras and Rho
4.4K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.4K
NF-κB-dependent Signaling Pathway
7.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.6K
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K

